Your browser doesn't support javascript.
loading
Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study.
Krens, Lisanne L; Simkens, Lieke H J; Baas, Jara M; Koomen, Els R; Gelderblom, Hans; Punt, Cornelis J A; Guchelaar, Henk-Jan.
Afiliación
  • Krens LL; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Simkens LH; Dept. of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Baas JM; Dept. of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Koomen ER; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gelderblom H; Dept. of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Punt CJ; Dept. of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Guchelaar HJ; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
PLoS One ; 9(11): e112201, 2014.
Article en En | MEDLINE | ID: mdl-25375154

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos